To Book About 55 Billion Yen Gain On Sale Of Roivant Sciences Shares In Parent-Only Q1 FY2025 Earnings
April 2 (Reuters) - Sumitomo Pharma Co Ltd 4506.T :
* SUMITOMO PHARMA CO - TO BOOK ABOUT 55 BILLION YEN GAIN ON
SALE
OF ROIVANT SCIENCES SHARES IN PARENT-ONLY Q1 FY2025 EARNINGS
Source text for Eikon: ID:nTSpb89f0f
Further company coverage: 4506.T
(Reporting by Kantaro Komiya)
((Kantaro.Komiya@thomsonreuters.com;))
Recent news on Sumitomo Pharma
See all newsSumitomo Pharma America Announces First Patient Receives Treatment In Phase 1/2A Study For Investigational Therapy Dsp-3077 For Retinitis Pigmentosa
Regarding A Report Concerning Sumitomo Pharma ( Company's Views On Gcr August 7 Report)
Brief: Sumitomo Pharma - Gotham City Research's August 3 Report Contains Numerous Statements That Are Clearly Inconsistent With Facts
Brief: Gotham City Research Holds Short Positions In Sumitomo Chemical And Sumitomo Pharmaceutical
Table: Sumitomo Pharma -Q1 group results (IFRS)